taurolidine has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braumann, C; Jacobi, CA; Kilian, M; Ordemann, J; Wenger, FA | 1 |
| Calabresi, P; Chatterjee, D; Cousens, LP; Darnowski, JW; Goulette, FA | 1 |
2 other study(ies) available for taurolidine and Experimental Neoplasms
| Article | Year |
|---|---|
Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Division; Colonic Neoplasms; Dose-Response Relationship, Drug; Fibrinolytic Agents; Heparin; Humans; Leukocytes; Leukocytosis; Leukopenia; Male; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Random Allocation; Rats; Taurine; Temperature; Thiadiazines; Time Factors; Tumor Cells, Cultured | 2003 |
Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Humans; Injections, Intraperitoneal; Male; Mice; Mice, Nude; Mitochondria; Neoplasms, Experimental; Prostatic Neoplasms; Taurine; Thiadiazines; Transplantation, Heterologous; Tumor Cells, Cultured | 2004 |